Teserpaturev/G47 Δ: First Approval
This article summarizes the milestones in the develo pment of teserpaturev/G47Δ leading to this first approval for the treatment of malignant glioma.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Asbestosis | Brain | Brain Tumor | Cancer | Cancer & Oncology | Cold Sores | Drugs & Pharmacology | Glioma | Herpes | Japan Health | Mesothelioma | Neuroblastoma | Neurology | Prostate Cancer